Laura Palagini, MD, PhD, is affiliated with the Psychiatric Clinic Department of Experimental Medicine at Azienda Ospedaliero-Universitaria Pisana in Pisa, Italy. Her publications from 2021 to 2023 focus on suicide risk, including the evaluation of orexin receptor antagonists and their potential impact on suicidal behaviors. She has also studied predictors of suicidal ideation and preparatory behaviors in bipolar disorder, emphasizing chronobiological dysrhythmicity and its association with hopelessness. Her work has appeared in Psychiatrist.com alongside frequent collaborators such as Jean Arthur Micoulaud-Franchi and Pierre A. Geoffroy.
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
